DS Healthcare Group, Inc. (DSKX)
OTOTC · Common · CUSIP 23336Q109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for DSKX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
23336Q109
Market Cap
Micro Cap · $15 Million
Previous Symbol
DSKXD (changed 11/30/2012)
Previous Name
Divine Skin, Inc.
Business: DS Healthcare Group, Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects.
Notes: Dec. 11, 2012 -- DS Healthcare Group, Inc. formerly named Divine Skin Inc., (OTCBB:DSKXD), a leading developer of personal care products, announced today it received confirmation that its application to list the Company's common stock on the NASDAQ Capital Market has been approved. Its common stock is expected to begin trading on the NASDAQ Capital Markets, under the same symbol DSKX at the opening of trading on December 13, 2012. ____________ MIAMI BEACH, Fla., November 29, 2012 -- Divine Skin Inc. (DSKX), a leading developer of personal care products, announced today that effective November 30, 2012 the Company will change its name to DS Healthcare Group, Inc., to be better reflect the company’s recent achievements and in line with short and long term goals. Furthermore, effective November 30, 2012 the Company shall also effectuate at 10 to 1 reverse split of its outstanding common stock, which the Company believes will result in a higher per share trading price of its Common Stock and may enable the Company to attract additional interest in its common stock from the investment community. The Company has also implemented the reverse stock split in order to comply with NASDAQ’s $3 minimum required bid price for initial listing on the NASDAQ Capital Market. The Company has recently applied for listing of its common stock on the NASDAQ Capital Market and believes that the reverse split will enable the Company to satisfy the minimum bid price requirement.

Company Contact

CEO
Renee Barch-Niles
Headquarters
1601 Green Road, Pompano Beach, FL 33064
Phone
888-404-7770 · Toll-Free 888-404-7770
Investor Relations
888-404-7700 · investors@DSHealthgroup.com
SEC EDGAR Filings
View filings »